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Abstract
Background Prosthetic implant infections caused by
Staphylococcus aureus and epidermidis are major chal-
lenges for early diagnosis and treatment owing to biofilm
formation on the implant surface. Extracellular DNA
(eDNA) is actively excreted from bacterial cells in bio-
films, contributing to biofilm stability, and may offer
promise in the detection or treatment of such infections.
Questions/purposes (1) Does DNA structure change
during biofilm formation? (2) Are there time-dependent
differences in eDNA production during biofilm formation?
(3) Is there differential eDNA production between clinical
and control Staphylococcal isolates? (4) Is eDNA produc-
tion correlated to biofilm thickness?
Methods We investigated eDNA presence during biofilm
formation in 60 clinical and 30 control isolates of S aureus and
S epidermidis.The clinical isolateswere isolated frompatients
with infections of orthopaedic prostheses and implants: 30
from infected hip prostheses and 30 from infected knee pros-
theses. The control isolateswere taken fromhealthyvolunteers
who had not been exposed to antibiotics and a hospital envi-
ronment during the previous 3 and 12 months, respectively.
Control S epidermidis was isolated from the skin of the ante-
cubital fossa, and control S aureuswas isolated from the nares.
For the biofilm experiments the following methods were used
to detect eDNA: (1) fluorescent staining with 40,6-diamidino-
2-phenylindole (DAPI), (2) eDNA extraction using a com-
mercial kit, and (3) confocal laser scanningmicroscopy for 24-
hour biofilm observation using propidium iodide and con-
canavalin-A staining; TOTO1-1 and SYTO1 60 staining
were used for observation and quantification of eDNA after 6
and 24 hours of biofilm formation. Additionally antibiotic
resistance was described.
Results eDNA production as observed by confocal laser
scanning microscopy was greater in clinical isolates than
controls (clinical isolatesmean±SD: 1.84%±1.31%; control
mean ± SD: 1.17% ± 1.37%; p\ 0.005) after 6 hours of
biofilm formation. After 24 hours, the amount of eDNA was
greater in biofilms ofS epidermidis than in biofilms ofS aureus
(S aureusmean± SD: 1.35%± 2.0%; S epidermidismean±
SD: 6.42% ± 10.6%; p\0.05). Clinical isolates of S aureus
and S epidermidis produced more eDNA than control isolates
at 6 hours of biofilm formation. The extraction method also
showed that clinical isolates produced substantially greater
amounts of eDNA than controls.
Conclusions S aureus and S epidermidis exhibit a dif-
ferential production of DNA with time. Clinical isolates
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associated with implant infections produce greater amounts
of eDNA than controls. Future research might focus on the
diagnostic value of eDNA as a surrogate laboratory marker
for biofilm formation in implant infections.
Clinical relevance eDNA should be considered as a
potential future diagnostic tool or even a possible target to
modify biofilms for successful treatment of biofilm-asso-
ciated infections.
Introduction
Microbial biofilms are an important factor in the patho-
physiology of prosthetic joint infections. Data show that
prosthetic joint infections account for 25% of failed knee
arthoplasties and 15% of failed hip arthroplasties [1, 2, 5].
Patients may be faced with prolonged and often futile
antimicrobial treatment where implant removal is ulti-
mately inevitable [8, 32]. Biofilms are a natural niche in
which bacteria may survive in an adverse environment
[17]. After initial bacterial adhesion on the implant surface,
colonization and proliferation occurs. Producing extracel-
lular matrix consisting of extrapolymeric substances, for
example, exopolysaccharides, proteins, and nucleic acids,
bacteria exhibit several mechanisms to survive: (1)
mechanical persistence; (2) metabolic changes such as
changes from an aerobic to an anaerobic state; (3)
exchanging genetic information, for example, resistance
genes; and (4) hiding from the immune system.
Multiple properties of Staphylococcus epidermidis and
Staphylococcus aureus are involved in biofilm formation
[9, 19]. The presence of extracellular DNA (eDNA), which
is actively released through designated cells, has generated
increased interest [25, 26]. The production of eDNA reg-
ulates the properties of extrapolymeric substances in
response to environmental influences. Biofilm formation
and production of extrapolymeric substances is related to
an active release of eDNA, originating from bacteria that
survived in an unfavorable environment. S aureus and S
epidermidis rely on different autolytic mechanisms in
which they use eDNA: eDNA produced by S epidermidis
plays an important role during the attachment phase
[21, 22]. This eDNA production is mediated by the auto-
lysin protein AtIE that induces lysis of a small bacterial
fraction enabling eDNA to be set free by S epidermidis
during the surface attachment [4, 13]. In contrast, eDNA of
S aureus originates from altruistic cell lysis and seems to
be responsible for biofilm maturation, which is controlled
by the cid operon [31]. Moreover, S aureus eDNA seems to
establish a functional net structure in the biofilm matrix to
tether cells together [6, 28]. Although the role of eDNA has
been investigated in basic biofilm research [18, 22, 25],
unresolved issues remain regarding eDNA in clinical bio-
films: a remarkable variability of eDNA was reported in a
study on clinical isolates of S epidermidis from patients
with orthopaedic wound and implant infections [28].
This topic might be important to clinicians because
prosthetic joint infection attributable to S aureus and S
epidermidis are associated with frequent failure of long-
term antibiotic treatment, revision surgery, and a debili-
tating course for patients. Determination of eDNA of the
causative pathogen may be a new tool to identify bacterial
strains with high eDNA content in biofilms as a potential
therapeutic target or to adjust the treatment decisions, for
example, early surgical intervention, to fight these infec-
tions more efficiently.
In the current study, we investigated the presence of
eDNA in S aureus and S epidermidis, isolated either from
patients with prosthetic joint infections or from control
subjects without active infections. Using separate methods
to observe DNA and eDNA and quantify eDNA and con-
focal laser scanning microscopy for observation, we asked:
(1) Does DNA structure change during biofilm formation?
(2) Are there time-dependent differences in eDNA pro-
duction during biofilm formation? (3) Is there differential
eDNA production between clinical and control Staphylo-
coccal isolates? (4) Is eDNA production correlated to
biofilm thickness?
Materials and Methods
Isolates and Strains Used in the Experiments
During 2000 to 2015, isolates from patients with infections
of orthopaedic prostheses and implants were collected and
stored at 80 C. The explanted prostheses had to be
transported from the operating theater to the microbiology
laboratory under standardized conditions within no more
than 2 hours to be included in our study. The explanted
prostheses were placed in sterile boxes filled with phos-
phate buffered saline (PBS) and vortexed first for 30
seconds. Thereafter, boxes with implants were sonicated
for 5 minutes and again vortexed for 30 seconds. The
sonicated fluid was distributed on blood agar plates and
cultured. Growing bacteria were counted and identified
using routine microbiologic laboratory methods. Addi-
tionally the results obtained after implant sonication were
confirmed with microbiologic cultures of intraoperative
fluid samples to exclude possible contamination [14].
The pathogens of 60 patients (27 male, 33 female) were
included in the study. The median age of the patients was
71 years (17–89 years). Thirty-one patients (51.5%) had
infection of a primary prosthesis and 29 patients (48.5%)
had infection of a secondary prosthesis.
Zatorska et al. Clinical Orthopaedics and Related Research1
123
Thus, overall 30 clinical isolates from infected hip
prostheses (hip) (15 S aureus and 15 S epidermidis) and 30
isolates from infected knee prostheses (knee) (15 S aureus
and 15 S epidermidis) were investigated. Control S aureus
(n =15) and S epidermidis (n =15) isolates were collected
from 30 volunteers without active infections who had not
been exposed to antibiotics for 3 months and to a hospital
environment during the previous 12 months. All S epi-
dermidis isolates were collected from skin of the
antecubital fossa. Control S aureus was isolated from the
nares. All isolates were identified using standard microbi-
ologic methods. S epidermidis DSM 3269 and S aureus
American Type Culture Collection (ATCC1) 25921
(ATCC, Manassas, VA, USA; www.atcc.org) were used as
reference strains.
Characteristics of Clinical and Control Isolates
Susceptibility Testing
All bacteria were tested for susceptibility to oxacillin,
rifampicin, ciprofloxacin, and vancomycin (disc diffusions
test), using standard laboratory methods according to the
European Committee on Antimicrobial Susceptibility




All experiments leading to biofilm formation were done on
overnight cultures growing at 37 C on Columbia agar +
5% sheep blood plates (bioMerieux SA, Marcy l’Etoile,
France). After incubation the isolates and the reference
strains were used for biofilm preparation using a modified
protocol described by Christensen et al. [3]. Other than in
the above-mentioned protocol, Brain Heart Infusion Broth
(Sigma-Aldrich, St Louis, USA) was used for all experi-
ments, as established in previous biofilm experiments
[11, 12]. The 96-well flat bottom plates (Corning1
Costar1; Corning Life Sciences, Tewksbury, MA, USA)
with bacterial suspensions were incubated for 24 hours at
37 C. Biofilm quantification was determined by measuring
the optical density after staining with crystal violet and
counting the viable bacteria (viable bacteria count) in the
biofilms.
For crystal violet staining, biofilms were fixed using 150
lL 2% glutaraldehyde/PBS. This fixing solution was cho-
sen for its superior preserving qualities. The extinction of
retained crystal violet was measured at 620 nm
wavelengths using the FLUOstar1 Omega microtiter-plate
reader (BMG LABTECH, Ortenberg, Germany). All bio-
film experiments were done five times for each isolate to
minimize variability. Additionally, confocal laser scanning
microscopy was used to confirm biofilm formation.
To measure viable bacteria in biofilms, the supernatant
containing planktonic cells was aspirated. The quantifica-
tion of viable bacteria counts of S epidermidis and S aureus
was assessed by serial dilutions; 100 lL of each dilution
was plated onto blood agar plates. After 48 hours incuba-
tion at 37 C, growth of colony forming units was counted.
Detection of eDNA
Measurements of eDNA were performed on 24-hour bio-
films using two methods: (1) fluorescence using 40, 6-
diamidino-2-phenylindole (DAPI), and (2) extraction of
eDNA using the polymer mediated enrichment kit.
DAPI
DAPI is a fluorescence stain method to observe the DNA in
cells. This staining method does not penetrate living bac-
terial cells such as staphylococci and was chosen to
establish the amount of eDNA in living biofilms [7]. This
procedure was performed overnight in black-bottom flat-
well plates (Corning1 Costar1; Corning Life Sciences).
Biofilms grown for 24 hours were washed twice with PBS,
air dried, and then stained with DAPI dissolved in PBS: 2
drops DAPI in 1 mL PBS (NucBlue1 Fixed Cell Ready
Probes1 Reagent; Thermo Fisher Scientific, Waltham,
MA, USA). To avoid cell penetration and thus staining
intracellular DNA, staining was applied for 5 minutes only.
The fluorescence of free eDNA in biofilms was measured
immediately using the FLUOstar1 Omega microplate
reader at 355/460 nm.
Extraction Using the Polymer Mediated Enrichment Kit
In this method 24-hour biofilms of the same isolate were
scraped and pooled in 200 lL PBS. After vortexing for 20
seconds to break up the biofilms, the suspension was fil-
tered using 0.22 Millex1-GS (Merck Millipore Ltd,
Tullagreen, Ireland) filters in a glass tube. eDNA was
extracted using the commercially available Polymer
Mediated Enrichment Free-Circulating DNA Extraction
Kit (Analytik Jena AG, Jena, Germany) according to the
manufacturer’s instructions. The amount of extracted
eDNA was measured using the NanoDropTM 2000c Spec-
trophotometer (Thermo Fisher Scientific).
eDNA Production in Staphylococcal Biofilms
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Confocal Laser Scanning Microscopy
Observation of 24-hour Biofilm Development in l-Dishes
in Dead Bacteria (reference strains)
To assess the role of eDNA during 24-hour biofilm
development, 1 mL of each reference (diluted in Brain
Heart Infusion Medium 1.5 9 107), was cultivated in single
24-well Ibidi l-Dishes (Ibidi Treat 1, 5 polymer coverslip,
tissue culture treated; Ibidi GmbH, Planegg/Martinsried,
Germany). Biofilms were grown at 37 C for 24 hours on
an orbital shaker. Every hour one well was taken off for
further investigation. Biofilms were washed two times in
PBS and fixed with 4% glutaraldehyde. First we observed
general DNA production and its structure at different times
of biofilm formation. Therefore, propidium iodide was used
to observe the dense DNA of the dead bacteria (Molecular
Probes1; Thermo Fisher Scientific). Polysaccharides, rep-
resenting the most characteristic fraction of the
extrapolymeric substances, were stained using con-
canavalin-A (ConA) (Sigma-Aldrich Corp, St Louis, MO,
USA).
eDNA Observation on 6- and 24-hour Biofilms
To observe eDNA expression and its distribution in live
biofilms, TOTO1-1 and SYTO1 60 (Molecular Probes1)
were used as recommended [24]. The working concentra-
tion of TOTO1-1 was 2 lmol/L and the counterstain
SYTO1 60 was used at a concentration of 10 lmol/L.
TOTO1-1 stains the free eDNA surrounding living and
dead cells, whereas SYTO1 60 is able to penetrate only the
cell wall of dead cells and stains the contained DNA red.
Biofilms were grown in Ibidi 96-well l-plates for optical
microscopy. Confocal laser scanning microscopy was done
after 6 and 24 hours. We used the same settings and region
of interest for every investigation. The images were made
using the LSM 780 confocal microscope system (Zeiss,
Oberkochen, Germany). ImageJ (https://imagej.nih.gov/ij/)
was used to score the images of stained biofilms. Every
measurement was made in triplicate.
Statistical Methods
Descriptive statistics, IBM SPSS1 Version 23.0 (IBM
Corp, Armonk, NY, USA) was used to analyze the data.
The unpaired two-sided Student’s t-test was used to com-
pare eDNA production of the two staphylococcal species
depending on the antibiotic exposure (control and clinical).
Spearman’s rank correlation was used to assess eDNA
production and biofilm thickness. Probability values less
than 0.05 were considered statistically significant.
Results
During the 24-hour observation of the reference strains we
observed differences in the pattern of biofilm formation: S
aureus ATCC25923 aggregated and formed various grape-
like aggregations of bacterial cells coated by single
polysaccharides before spreading on the surface and
forming a biofilm layer (Fig. 1A–B). In contrast, S epi-
dermidis biofilms started with scattered cells spreading
over the surface until reaching confluence and their maxi-
mum thickness at 24 hours without forming grapes or
clusters (Fig. 1C–D). Most interestingly, we observed tiny
filamentous bond-like structures between dead cells at
different stages depending on the staphylococcal species.
In S aureus biofilms the filaments were detected mainly
after 5 to 6 hours of biofilm formation (Fig. 1A–B, arrow),
whereas the filaments in S epidermidis biofilms were
detected after 24 hours of biofilm formation (Fig. 1E,
arrow).
eDNA staining of 24-hour biofilms with TOTO1-1
revealed less eDNA in biofilms of all S aureus isolates than
eDNA in biofilms of all S epidermidis isolates (S aureus
mean ± SD: 1.35% ± 2.0%; S epidermidis mean ± SD:
6.42% ± 10.6%; p \ 0.05). The same staining showed
greater production of eDNA in all clinical isolates at 6
hours regardless of their species (clinical isolates mean ±
SD: 1.84% ± 1.31%; control mean ± SD: 1.17% ± 1.37%;
p\ 0.005). However, only biofilms of S aureus isolates
showed differences in eDNA production at 6 and 24 hours
(6-hour biofilms: clinical isolates mean ± SD: 1. 97% ±
1.51%; control mean ± SD: 0.88% ± 0.72%; p\ 0.005;
24-hour biofilms: clinical isolates mean ± SD: 1.83% ±
2.30%; control mean ± SD: 0.38% ± 0.19%; p\ 0.05).
The amount of eDNA decreased in clinical and control
biofilms of S aureus at 24 hours.
For S epidermidis there was no difference of eDNA
between clinical isolates and controls (6-hour clinical iso-
lates mean ± SD: 1.71% ± 1.07%; control mean ± SD:
1.45% ± 1.78%; 24-hour clinical isolates mean ± SD:
6.98% ± 12.62%; control mean ± SD: 5.3% ± 4.57%;
(Fig. 2). The amount of eDNA at 24-hours was increased in
clinical and control biofilms compared with 6-hour bio-
films. A dense net of filamentous structures stained green
with TOTO1-1 was seen on the confocal laser scanning
microscopy image of S epidermidis on the 24-hour
biofilms.
Regarding polymer mediated enrichment extraction on
biofilms, all clinical isolates showed greater amounts of
eDNA than biofilms of control isolates (clinical isolates
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mean ± SD: 88.6 ± 14.8 ng/lL versus control isolates
mean ± SD: 69.6 ± 20.6 ng/lL; p\ 0.005). In contrast,
there was no difference in eDNA production between
clinical and control biofilms using the fluorescence DAPI
stain (clinical isolates mean ± SD: 2551 ± 909 fluores-
cence units; control mean ± SD: 2500 ± 1419 fluorescence
units) (Table 1). Comparing clinical and control isolates of
S aureus and S epidermidis, both methods showed con-
cordant results: the amount of eDNA in biofilms of S
aureus clinical isolates was greater than on biofilms of S
aureus control isolates (p \ 0.001) (Table 1). However,
DAPI but not polymer mediated enrichment showed that
eDNA in biofilms of S epidermidis clinical isolates was
lower than on biofilms of S epidermidis control isolates
Fig. 1A–E (A) The S aureus
biofilm after 6 hours of incuba-
tion shows grape-like groups
and suspected eDNA filaments
(arrow) before spreading. (B) A
magnification is shown of Illus-
tration A, using a filter to better
observe the filamentous bonds
(arrow). (C) After 24 hours of
incubation, a biofilm layer is
forming. (D) The S epidermidis
biofilm after 6 hours of incuba-
tion shows scattered cells over
the surface. (E) After 24 hours
of incubation, suspected eDNA
filaments (arrow) are produced.
(Original magnification, 91000;
scale bar: 5 lm).
eDNA Production in Staphylococcal Biofilms
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Table 1. Amounts of eDNA measured for clinical and control S aureus and S epidermidis




Confocal laser scanning microscopy mean % area eDNA (TOTO1-1; green)*
6-hour 24-hour
S aureus (n = 45) 2446 ± 2577 74.9 ± 21.6 1.61 ± 1.39 1.35 ± 2.00
S epidermidis (n = 45) 2622 ± 1113 89.6 ± 12.7 1.62 ± 1.33 6.42 ± 10.60
No difference No difference No difference p = 0.01
S aureus
Clinical isolates (n = 30) 2814 ± 1058 84 ± 18.12 1.97 ± 1.51 1.83 ± 2.30
Control isolates (n = 15) 1707 ± 720 57 ± 16.2 0.88 ± 0.72 0.38 ± 0.19
p = 0.001 p = 0.001 p = 0.002 p = 0.01
S epidermidis
Clinical isolates (n = 30) 2287 ± 647 93 ± 8.5 1.71 ± 1.07 6.98 ± 12.62
Control isolates (n = 15) 3292 ± 1520 83 ± 16.4 1.45 ± 1.78 5.3 ± 4.57
p = 0.005 p = 0.005 No difference No difference
Clinical isolates (n = 60) 2551 ± 909 88.6 ± 14.8 1.84 ± 1.31 4.41 ± 9.36
Control isolates (n = 30) 2500 ± 1419 69.6 ± 20.6 1.17 ± 1.37 2.84 ± 4.04
No difference p = 0.001 p = 0.03 No difference
*Cyanine dimer TOTO1-1 to stain extracellular DNA (green); DAPI = 4’,6-diamidino-2-phenylindole; PME = polymer mediated enrichment.
Fig. 2A–D Clinical S epider-
midis biofilms after (A) 6
hours and (B) 24 hours, and
control isolates of S epidermidis
biofilms after (C) 6 hours (D)
and 24 hours are shown. The
amount of dead cells DNA (red)
measured after 6 hours was
higher (p\ 0.005) on biofilms
of clinical isolates of S epider-
midis than for control isolates.
Generally eDNA (green) pro-
duction was higher (p \ 0.05)
on all biofilms of clinical iso-
lates than on control isolates.
(Original magnification, 91000;
scale bar: 5 lm).
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(mean ± SD, 3292 ± 1520 fluorescence units; p\ 0.05)
(Table 1).
Biofilm thickness determined using optical density
depended mainly on the species, and whether the isolate
was a clinical isolate or a control isolate from the skin of
healthy control subjects. There were no differences
between optical densities of biofilms of S epidermidis (0.42
± 0.29) and S aureus (0.30 ± 0.19). Furthermore no dif-
ferences between optical densities of biofilms of all clinical
(0.40 ± 0.28) compared with control isolates (0.29 ± 0.18)
were observed. The biofilm optical densities of S aureus
clinical isolates (0.35 ± 0.2) were greater than those of S
aureus control isolates (0.2 ± 0.13; p\0.005). The biofilm
optical densities of S epidermidis control isolates (0.37 ±
0.17) were greater than those of S aureus control isolates
(0.2 ± 0.13; p \ 0.005). Spearman’s rank correlation
showed no relationship between production of eDNA by S
aureus (clinical and control isolates) and biofilm produc-
tion (rho = 0.29; p = 0.05). Similarly, no relationship was
observed using Spearman’s rho between production of
eDNA by S epidermidis (clinical and control isolates) and
biofilm (rho = 0.12; p = 0.42).
Antibiotic susceptibility testing revealed less suscepti-
bility to antimicrobials among the clinical isolates
compared with controls. The clinical S epidermidis isolates
were resistant to oxacillin (15/30), rifampicin (nine of 30),
and ciprofloxacin (14/30). Control S epidermidis isolates
were resistant to oxacillin and ciprofloxacin (three of 15).
In comparison, clinical S aureus was resistant to oxacillin
(eight of 30), ciprofloxacin (seven of 30), and rifampicin
(one of 30). All tested isolates were sensitive to van-
comycin (Table 2).
Discussion
eDNA in biofilms plays an important role in biofilm for-
mation and maturation [4, 18]. It is actively produced by a
small bacterial population, and is essential for biofilm
structure and stability [27]. In addition to its role in biofilm
structure and stability, eDNA serves an additional role in
antimicrobial resistance [7]. As such, eDNA may play a
potential role in the diagnosis and treatment of biofilm-
related infections. Using confocal laser scanning micro-
scopy for observation, and separate methods to observe and
quantify DNA and eDNA we asked (1) whether DNA
structure changes during biofilm formation, (2) are there
time-dependent differences in eDNA production during
biofilm formation, (3) is there differential eDNA produc-
tion between clinical and control Staphylococcal isolates,
and (4) is eDNA production correlated to biofilm
thickness?
One limitation of our study is that the observation
method using confocal microscopy and the extraction
method cannot be directly compared although both meth-
ods were used for different purposes. The extraction
method is robust and may be used for experiments in future
clinical studies. Additionally, the fluorescent stain SYTO1
60 has a very short half-life making quantification prob-
lematic. The DAPI stain, which we intentionally used to
selectively stain eDNA proved to be quite nonspecific in
contrast to previous reports where DAPI penetrated the
cells only after longer staining times [7, 16]. Finally, the
use of brain heart infusion broth as the growth medium
could be seen as a limitation since, in general, tryptic soy
broth medium is used to enhance biofilm formation of S
epidermidis producing polysaccharide intercellular adhe-
sion [30]. Knowing that alternative pathways of biofilm
formation based on the extracellular matrix binding protein
(Embp) or through the release of eDNA are present, we
opted for brain heart infusion broth based on our previous
experiences with this medium [11, 12].
Propidium iodide stains DNA either in dead cells or
dense eDNA structures [24]. Overall, eDNA is pivotal for
the formation of biofilms in clinical isolates of S epider-
midis and S aureus [22]. We observed filamentous
structures stained by propidium iodide in S aureus (Fig. 1
A, arrow) and S epidermidis, (Fig. 1D, arrow). Similar
structures were observed in live biofilms of S epidermidis
stained with TOTO1-1. TOTO1-1 stain is not cell per-
meable and exhibits a high DNA binding affinity owing to
its four positive charges [24]. Furthermore, TOTO1-1 stain
has no time constraints and it shows high sensitivity for
observation of tiny and delicate eDNA structures. It may be
possible that these filaments represent eDNA forming a
network, as described by Dengler et al. [6].
Table 2. Antimicrobial characteristics of the clinical and control isolates












Oxacillin resistant 4 (27%) 4 (27%) 0 7 (47%) 8 (53%) 3 (20%)
Rifampicin resistant 0 1 (7%) 0 5 (33%) 4 (27%) 0
Ciprofloxacin resistant 2 (13%) 5 (33%) 0 7 (47%) 7 (47%) 3 (20%)
Vancomycin resistant 0 0 0 0 0 0
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TOTO1-1 staining to observe and quantify eDNA using
confocal microscopy showed greater eDNA production in S
epidermidis than in S aureus at 24 hours. An explanation for
this finding may be that S aureus, being mostly a transient
part of the human microbiota, starts biofilm formation only
under certain conditions [23], whereas S epidermidis as a
constant part of the human skin microbiota, relies on the
constant production of eDNA to stabilize biofilms and to
persist on different surfaces such as the human skin [10]. At 6
hours we detected substantially higher amounts of eDNA in
biofilms of clinical isolates of S aureus and S epidermidis
compared with control isolates, but not at 24 hours owing to
the higher variance. The high amount of eDNA at 6 hours
confirms previous studies in which S aureus used eDNA in
the initial attachment and accumulation phase [15, 20, 29] .
Qin et al. [27] indirectly supported this finding, stating that
DNase, as DNA cleaving enzyme, was able to disturb or
negatively influence biofilms during the first 6 hours of
biofilm formation.
In the current study, biofilm thickness of all isolates was
assessed using optical density measurements after crystal
violet staining. According to our results, biofilm thickness did
not correlate with eDNA production, as reported by Dor-
oshenko et al. [7]. Biofilms of clinical isolates showed no
differences in optical densities compared with biofilms of
control isolates. Confocal laser scanning microscopy was
most useful showing the growth pattern during biofilm
formation.
Information regarding eDNA production of clinical
isolates is scarce and our results indicate that clinical iso-
lates of S aureus und S epidermidis produced substantially
more eDNA than control isolates. Staining with TOTO1-1
and SYTO1 60 allowed observation and quantification of
eDNA using confocal laser scanning microscopy. Further
research is needed to determine whether the amount of
eDNA produced by clinical isolates might be considered as
an additional diagnostic tool in staphylococcal biofilm
infections. eDNA also might be a future target to modify or
disrupt biofilms. Finally, characterizing pathogens by their
eDNA production may serve as an outcome predictor of
prosthetic joint infections and thus play a role in treatment
decisions.
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